The Relationship Between Perioperative Use of Esketamine and Postpartum Depression Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials DOI Creative Commons

Yuansheng Cao,

Lijuan Fu, Xianjie Zhang

et al.

Neuropsychiatric Disease and Treatment, Journal Year: 2024, Volume and Issue: Volume 20, P. 1041 - 1048

Published: May 1, 2024

Purpose: To determine whether perioperative esketamine use decreases the risk of postpartum depression (PPD). Methods: Online search PubMed, Web Science, and Embase was conducted to identify relevant studies. Key words for included, but were not limited to, depression, esketamine, clinical trials. The mean standard deviation Edinburgh Postnatal Depression Scale (EPDS) scores extracted from studies as primary parameters. Results: literature identified 226 articles, which 5 met criteria enrolled in study. In total, 886 patients taken into analysis. EPDS group lower than those control at early stage puerperium (WMD=− 2.05, 95% CI: − 3.77, 0.34, p =0.019), whereas there no significant difference middle later stages 1.41, 2.86, 0.04, =0.056). sensitivity analyses indicated that result stable, it unreliable stages. results Egger's test publication bias. Conclusion: Perioperative contributes a PPD further verify this conclusion, more high-quality are required. Keywords: pregnant women, mental health

Language: Английский

Psychometric testing of Chinese version of screening tools (PASS) and GAD among perinatal population: hospital based evidence 2023 DOI Creative Commons
Xiaoying Zhong, Mei He, Xiujing Guo

et al.

BMC Psychiatry, Journal Year: 2025, Volume and Issue: 25(1)

Published: March 11, 2025

Anxiety disorders are increasing worldwide, untreated anxiety is linked to maternal and child health outcomes. The purpose of this study test psychometric properties the Perinatal Screening Scale (PASS) among Chinese women. PASS was translated into following Beaton's intercultural debugging guide. A total 494 women in antenatal postnatal phase participated ( 268 186 ) were recruited between March 2023 July from two hospitals Sichuan Province, China. instruments included demographic characteristics form, PASS, Edinburgh Postnatal Depression (EPDS), Generalized Disorder-7 (GAD-7). confirmatory factor analysis (CFA), internal consistency reliability convergent validity assessed. mean age participant 31.67 years (SD = 3.78; range 23 49). CFA showed that four-factor model Chinese-PASS had an excellent fit data χ2 1481.2477; df 425; χ2/df 3.485; RMSEA 0.071; CFI 0.871; NNFI 0.828; TLI 0.859; IFI 0.871). Cronbach's alpha coefficient scale 0.950, split-half 0.907. significantly correlated with EPDS (r 0.732) GAD-7 0.763). area under ROC curve for scores 0.91 (SE 0.01; 95% CI 0.89–0.94). At cut-off score ≥ 19.5, sensitivity 0.87. 0.89 0.02; 0.86–0.92). 3.5, 0.82. result show a reasonably adequate can be used screen disorder during perinatal period.

Language: Английский

Citations

0

Impact of esketamine intravenous analgesic pump on pain and depression post-cesarean DOI Creative Commons
Xiaoqiang Zhang, Shuang Li, Xiaolin Qin

et al.

BMC Surgery, Journal Year: 2025, Volume and Issue: 25(1)

Published: April 8, 2025

Postoperative pain and psychological well-being in postpartum women following cesarean section are critical for optimal maternal recovery. Traditional analgesics often have limitations side effects, prompting the need alternative solutions. This study evaluates impact of an esketamine intravenous analgesic pump on postoperative status section. A comprehensive retrospective evaluation was conducted at our institution from October 2021 to July 2023, including 168 patients who underwent delivery. The observation group (n = 82) received via pump, while control 86) traditional therapy. Data collected included demographic information, surgical details, (assessed using Visual Analog Scale, VAS), Edinburgh Postnatal Depression EPDS), recovery metrics, adverse reactions. demonstrated consistently lower VAS scores all time points compared group, indicating superior control. EPDS were significantly 3, 5, 14 days postoperatively, suggesting better outcomes. incidence depression also days. Recovery metrics such as first ambulation, flatus, initiation lactation improved group. There no significant differences reactions between groups. use Esketamine Intravenous Analgesic Pump reduces within It promotes early breastfeeding without reactions, making it a valuable addition care.

Language: Английский

Citations

0

Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis DOI Creative Commons
Haoyan Li,

Wen-Jing Xu,

Yamei Wang

et al.

Frontiers in Psychiatry, Journal Year: 2025, Volume and Issue: 16

Published: April 15, 2025

Background Postoperative depression (POD) represents a serious complication in surgical patients, exacerbating morbidity and mortality rates while imposing substantial economic burden on healthcare systems. Despite its widespread clinical use, the role of esketamine, an NMDA receptor antagonist with rapid antidepressant effects, remains understudied perioperative settings. Therefore, we conducted systematic review meta-analysis to assess efficacy esketamine postoperative depression. To evaluate effect incidence severity different types surgery by randomized controlled trial, investigate whether can effectively reduce score short long term after promote application analgesia-antidepressant combination. Method Searched PubMed, Cochrane Library, Web Science, Medline identify trials using drug analyzed data Review Manager 5.3. Results We included total 8 involving 1724 patients who met criteria. The revealed that treatment, compared control groups, significantly reduced POD. Improvements were observed at 1 week (RD -0.09, 95% CI [-0.13, -0.05], P < 0.0001, I²=84%), 2 weeks -0.08, -0.03], 0.00001, I²=97%), long-term follow-up -0.06, [-0.10, -0.02], P=0.0002, I²=79%). Conclusion Esketamine demonstrates reducing POD severity, although use is associated increased risk adverse effects. Also, method injection, duration administration number doses may have results. further exploration appropriate dosing regimens multi-modal strategies necessary mitigate Systematic registration https://www.crd.york.ac.uk/PROSPERO/ , identifier CRD42024506329.

Language: Английский

Citations

0

Does Esketamine Peripartum Intervention Reduce the Risk of Postpartum Depression? A Systematic Review and Meta-Analysis of Obstetric Anesthesia and Analgesic Approaches DOI
Yiran Li, Xingyu Hu, Xintong Chen

et al.

Published: Jan. 1, 2025

Language: Английский

Citations

0

The Relationship Between Perioperative Use of Esketamine and Postpartum Depression Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials DOI Creative Commons

Yuansheng Cao,

Lijuan Fu, Xianjie Zhang

et al.

Neuropsychiatric Disease and Treatment, Journal Year: 2024, Volume and Issue: Volume 20, P. 1041 - 1048

Published: May 1, 2024

Purpose: To determine whether perioperative esketamine use decreases the risk of postpartum depression (PPD). Methods: Online search PubMed, Web Science, and Embase was conducted to identify relevant studies. Key words for included, but were not limited to, depression, esketamine, clinical trials. The mean standard deviation Edinburgh Postnatal Depression Scale (EPDS) scores extracted from studies as primary parameters. Results: literature identified 226 articles, which 5 met criteria enrolled in study. In total, 886 patients taken into analysis. EPDS group lower than those control at early stage puerperium (WMD=− 2.05, 95% CI: − 3.77, 0.34, p =0.019), whereas there no significant difference middle later stages 1.41, 2.86, 0.04, =0.056). sensitivity analyses indicated that result stable, it unreliable stages. results Egger's test publication bias. Conclusion: Perioperative contributes a PPD further verify this conclusion, more high-quality are required. Keywords: pregnant women, mental health

Language: Английский

Citations

2